Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION (Details 3)

v3.22.4
SHARE-BASED COMPENSATION (Details 3) - Stock Options [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares Options Outstanding, Beginning 5,489,492  
Exercise Price Outstanding, Beginning $ 4.23  
Weighted Average Remaining Contractual Life (Years) 6 years 18 days 6 years 6 months 21 days [1]
Weighted-Average Grant Date Fair Value,Beginning $ 2.27  
Number of Shares Options Granted 2,686,337  
Exercise Price Granted $ 2.81  
Weighted-Average Grant Date Fair Value,Granted $ 2.21  
Number of Shares Options, Forfeited (65,634)  
Exercise Price Forfeited $ 4.50  
Weighted-Average Grant Date Fair Value,Forfeited $ 2.52  
Number of Shares Options Expired (298,017)  
Exercise Price Expired $ 5.26  
Weighted-Average Grant Date Fair Value,Expired $ 2.82  
Number of Shares Options Outstanding, Ending 7,812,178 [1] 5,489,492
Exercise Price Outstanding, Ending $ 3.70 [1] $ 4.23
Weighted-Average Grant Date Fair Value,Ending $ 2.23 [1] $ 2.27
Number of Shares Exercisable at end of period [2] 4,525,905  
Exercise Price Options exercisable at end of period [2] $ 4.03  
Weighted Average Remaining Contractual Life (Years) exercisable [2] 4 years 10 months 2 days  
Weighted-average grant date fair value exercisable [2] $ 2.13  
[1] There was no aggregate intrinsic value of all stock options outstanding as of December 31, 2022.
[2] There was no aggregate intrinsic value of all vested/exercisable stock options as of December 31, 2022.